Semaglutide 2.4 mg in adults with overweight/obesity AND type 2 diabetes.
9.6% body-weight reduction vs 3.4% placebo at 68 weeks.
Summary is editorial; consult the original publication for the full methodology and statistical detail.
Five minutes. Free. No pressure.